Try GOLD - Free
Romaco at CPHI & PMEC India 2024: Processing and more
Express Pharma
|December 2024
Romaco will be taking advantage of this year's CPHI & PMEC India to show its complete processing portfolio for granulating, tableting and coating pharma solids. The pharma machinery manufacturer also provides numerous primary, secondary and final packaging solutions for a wide variety of products
-
Romaco's processing technologies will be at the center of the one-stop solutions supplier's exhibit at this year's CPHI & PMEC India. Fluid bed processors from Romaco Innojet, tablet presses from Romaco Kilian and drum coaters from Romaco Tecpharm are suited for a very broad range of products and impress with the highest levels of quality, efficiency and sustainability. Targeted measures to save energy and raw materials shorten processing times, cut the costs for manufacturing and improve the machines' carbon footprint. Also, temperature-sensitive products, which are typically high-volume, can be processed and compressed absolutely safely thanks to special technological features.
Users and prospects also have a chance to develop and test their products on Romaco's laboratory equipment at Romaco India's new Customer Experience Centre in Hyderabad. Here, they can benefit from expert advice and support for scale-up trials, process optimization and competent troubleshooting. The Romaco India Sales & Service Centre additionally offers a comprehensive range of machine training options covering processing and packaging for local manufacturers of pharmaceuticals and nutraceuticals.
CPHI and PMEC India is an ideal platform to share experiences with industry insiders and demonstrate selected technologies along the pharmaceutical process chain.
KTP 720X double-sided rotary press from Romaco Kilian This story is from the December 2024 edition of Express Pharma.
Subscribe to Magzter GOLD to access thousands of curated premium stories, and 10,000+ magazines and newspapers.
Already a subscriber? Sign In
MORE STORIES FROM Express Pharma
Express Pharma
Future opportunities in biologics and biosimilars will demand significant investment
Semaglutide's patent expiry in India in March 2026 has become the immediate trigger for the next wave of pharmaceutical development activity, but the larger opportunity goes well beyond semaglutide itself.
1 mins
April 2026
Express Pharma
Gandhi Automations elevates loading bay efficiency with advanced dock leveler solutions
Engineered systems from Gandhi Automations Pvt Ltd enhance safety, durability and seamless material flow
2 mins
April 2026
Express Pharma
Redefining humidity control in pharma manufacturing
Bry-Air systems reflect shift towards material-based humidity control in pharma manufacturing
2 mins
April 2026
Express Pharma
2026 amendments to NDCT Rules: Foreword to India's biosimilars story or a step too short?
Kosturi Ghosh, Partner, and Ajeya B G, Sr Associate, in the Corporate practice at Trilegal, assess India's 2026 NDCT amendments as a timely push for biosimilars, but not enough on their own. The article highlights that stronger policy clarity and ecosystem support will be critical to truly unlock growth.
4 mins
April 2026
Express Pharma
Optima advances digital twins to boost efficiency in pharmaceutical turnkey machines
Virtual testing, training and simulation tools enhance performance in complex manufacturing environments
7 mins
April 2026
Express Pharma
Complete environmental monitoring solution – testo Saveris Pharma
There are several critical applications in the industry like research and development that demand for continuous & reliable monitoring of important environmental parameters.
3 mins
April 2026
Express Pharma
Flexotherm heating tapes & cords
Typical Applications of Heating Tapes and Cords in Industrial Solvent Handling
1 mins
April 2026
Express Pharma
Safeguarding the pharma excipients supply chain
Adding excipient details to QR codes of the top 300 drugs may not be a tough task. But as CDSCO plans to expand QR codes to cover other critical drug categories in phases, all segments of the pharma value chain need to tighten their systems, analyses Viveka Roychowdhury
15 mins
April 2026
Express Pharma
This is only the beginning of a much larger global patent-cliff cycle
As the patent expiry of semaglutide is almost there in India, several Indian pharma firms are preparing to introduce generic versions, highlighting the sector's agility in responding to high-value loss-of-exclusivity opportunities.
1 min
April 2026
Express Pharma
Leading people in the age of Al
As Al reshapes pharma, HR leadership is being drawn into a deeper question that goes beyond technology to the future of people and work, finds Lakshmipriya Nair
8 mins
April 2026
Listen
Translate
Change font size
